Butorphic will offer veterinarians the quality routine-use opiate they currently purchase at an economic value unavailable in the marketplace today.
Shenandoah, IA (PRWEB) February 13, 2010
LLOYD, Inc. is pleased to announce the introduction of their newest addition to the veterinary injection family of products, Butorphic® (butorphanol tartrate) sterile solution, a staple in veterinary analgesia. Butorphic (10mg/mL) will be packaged in convenient 20 mL, multi-use, vials with an economical price point typically limited to larger 50 mL purchases.
“We are proud to introduce yet another key product offering in our line of veterinary sedative and analgesic injections,” states LLOYD’s Director of Sales & Marketing, Hoan Tran. “Butorphic will offer veterinarians the quality routine-use opiate they currently purchase at an economic value unavailable in the marketplace today.”
Butorphic® will be launched officially at the LLOYD, Inc. exhibit (754) during the Western Veterinary Conference in Las Vegas, 14-18 February 2010. At the end of March 2010, the product will be available for shipment.
For more information about Butorphic® and LLOYD’s complete line of veterinary products visit: http://www.lloydinc.com.
ABOUT LLOYD, Inc.
LLOYD, Inc. (Shenandoah, IA), develops, manufactures and markets unique pharmaceutical and nutritional products for veterinary and human medicine. Working in partnership with more than sixty distributors and private label clients, LLOYD, Inc. products can be found in most veterinary clinics and schools of veterinary medicine in the United States.